Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016639
Filing Date
2022-11-07
Accepted
2022-11-07 16:30:41
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20220930x10q.htm   iXBRL 10-Q 1295263
2 EX-10.1 nviv-20220930xex10d1.htm EX-10.1 100598
3 EX-31.1 nviv-20220930xex31d1.htm EX-31.1 13866
4 EX-31.2 nviv-20220930xex31d2.htm EX-31.2 13574
5 EX-32.1 nviv-20220930xex32d1.htm EX-32.1 7524
6 EX-32.2 nviv-20220930xex32d2.htm EX-32.2 7585
  Complete submission text file 0001558370-22-016639.txt   5705050

Data Files

Seq Description Document Type Size
7 EX-101.SCH nviv-20220930.xsd EX-101.SCH 41151
8 EX-101.CAL nviv-20220930_cal.xml EX-101.CAL 41952
9 EX-101.DEF nviv-20220930_def.xml EX-101.DEF 168692
10 EX-101.LAB nviv-20220930_lab.xml EX-101.LAB 352902
11 EX-101.PRE nviv-20220930_pre.xml EX-101.PRE 285612
68 EXTRACTED XBRL INSTANCE DOCUMENT nviv-20220930x10q_htm.xml XML 936217
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 221365881
SIC: 3841 Surgical & Medical Instruments & Apparatus